Preceding weeks have made clear that COVID-19 continues to spread and is paralyzing the world. Times are unprecedented and show us how vulnerable we are and how we depend on each other. As a service organization – highly specialized in virology – we will commit ourselves to realign our resources, equipment and materials to new initiatives to test anti-virals, immune modulators and vaccines in the battle against COVID-19. We like to thank our regular and repeat customers, because they also give COVID-19 intervention strategies ample attention and – together with us – show the flexibility to prioritize the programs, making it possible to gear exceptional efforts to new COVID-19 drug and vaccine medication at Viroclinics-DDL.
- Viroclinics-DDL’s laboratory sites in Rotterdam, Rijswijk and Schaijk will readjust most of their day-to-day operations to COVID-19 (pre) clinical trial support;
- A specialized operational team is installed to deal with daily contingency and capacity planning;
- We will provide (cold) supply chain solutions to prepare for large scale trials dedicated to COVID-19;
- We will operate using our high containment BSL2 / BSL3 laboratories at multiple locations using validated molecular, cellular and preclinical analyses models.